Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

332
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
332
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

443
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
443
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

155
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
155
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

467
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
467
Binge Eating Disorders01:23

Binge Eating Disorders

210
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
210
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

558
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
558

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Esophageal Clearance Assessed by High-Resolution Impedance Manometry in Achalasia: A Prospective Study With 1-Year Follow-up.

The American journal of gastroenterology·2026
Same author

PPI-Refractory GERD in Systemic Sclerosis Is Driven by Distinct Esophageal and Gastric Motility Abnormalities.

medRxiv : the preprint server for health sciences·2026
Same author

Delayed gastric emptying identifies a high-risk clinical subgroup in patients with systemic sclerosis.

Rheumatology (Oxford, England)·2026
Same author

Fecal incontinence in systemic sclerosis: prevalence, clinical correlates, and impact on quality of life.

Revista espanola de enfermedades digestivas·2025
Same author

Oesophageal dysmotility patterns are associated with distinct clinical phenotypes and prognosis in patients with systemic sclerosis.

Rheumatology (Oxford, England)·2025
Same author

Effect of STW 5-II (Iberogast-N) on Tolerance to Gastric Gas in Patients With Functional Dyspepsia. The IBO-2 Study.

Neurogastroenterology and motility·2025
Same journal

The Drought of Evidence for Water Intake to Manage Constipation Symptoms May Be Ending.

Neurogastroenterology and motility·2026
Same journal

L-Carnitine Improves Visceral Hypersensitivity and Colonic Hyperpermeability in a Rat Model of Irritable Bowel Syndrome.

Neurogastroenterology and motility·2026
Same journal

Letter to the Editor: "Magnesium-Rich Mineral Water Improves Stool Consistency and Bowel Habits in Healthy Subjects: A Randomized Controlled Trial".

Neurogastroenterology and motility·2026
Same journal

Expert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: 'Auckland Classification' v1.0.

Neurogastroenterology and motility·2026
Same journal

Editorial: Bodily Maps of Emotions in Irritable Bowel Syndrome-Implications for Brain-Gut and Gut-Brain Interventions.

Neurogastroenterology and motility·2026
Same journal

ReFerm® a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome.

Neurogastroenterology and motility·2026
See all related articles

Related Experiment Video

Updated: Oct 4, 2025

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.1K

Management of bloating.

Jordi Serra1,2

  • 1Digestive System Research Unit, University Hospital Vall d'Hebrón, Barcelona, Spain.

Neurogastroenterology and Motility
|February 10, 2022
PubMed
Summary
This summary is machine-generated.

Abdominal bloating is common in irritable bowel syndrome and functional gastrointestinal disorders, impacting daily life. New research explores its prevalence, severity, and effective management strategies, including dietary changes and targeted therapies.

Keywords:
abdominal distensionbloatingintestinal fermentationintestinal gasvisceral sensitivity

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

426
Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

746

Related Experiment Videos

Last Updated: Oct 4, 2025

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.1K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

426
Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

746

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Patient-Reported Outcomes

Background:

  • Abdominal bloating is a prevalent symptom in functional gastrointestinal disorders, particularly irritable bowel syndrome (IBS).
  • Gas-related symptoms significantly impact patients' daily lives and are associated with other symptoms like pain and constipation.
  • Understanding the clinical characteristics and relevance of bloating is crucial for effective patient management.

Purpose of the Study:

  • To present a new validated questionnaire for assessing the prevalence and impact of gas-related symptoms.
  • To evaluate the association between bloating severity and other clinical factors in functional gastrointestinal disorders.
  • To review current and emerging management strategies for abdominal bloating.

Main Methods:

  • Validation of a new questionnaire for gas-related symptoms.
  • Assessment of bloating severity in relation to abdominal pain, constipation, and somatization.
  • Review of non-pharmacological (dietary, prebiotics, probiotics) and pharmacological (prokinetics, antispasmodics, antibiotics, secretagogues) treatments.
  • Evaluation of biofeedback therapies for specific patient subgroups.

Main Results:

  • Gas-related abdominal symptoms are prevalent in IBS patients and have a measurable impact on daily life.
  • Severe bloating is associated with increased abdominal pain, constipation, and somatization.
  • Various interventions, including dietary modifications, probiotics, prokinetics, antispasmodics, secretagogues, and biofeedback, show potential for managing bloating.

Conclusions:

  • Validated tools are essential for quantifying the prevalence and impact of bloating.
  • Bloating is a complex symptom with significant clinical implications in functional gastrointestinal disorders.
  • A multimodal approach combining lifestyle changes, targeted medications, and therapies like biofeedback is key to managing abdominal bloating effectively.